B.Grimm Pharma

B.Grimm Pharma is a leading developer and provider of pharmaceutical and healthcare solutions in Thailand, operating as a core pillar of the B.Grimm Group conglomerate. The company is involved across the entire value chain, including research and development, manufacturing, marketing, sales, and distribution of generic pharmaceuticals, nutraceuticals, and cosmeceuticals. Its mission is to expand access to high-quality healthcare products through a philosophy of 'Doing Business with Compassion.' The company was significantly expanded in 2022 through the acquisition of Medline, Unison Laboratories, F.C.P., and All Research, creating an integrated healthcare network. B.Grimm Pharma maintains a strong presence in both public and private hospitals across Thailand and is increasingly expanding its international footprint in Southeast Asia and beyond.